Advanced Enzyme Technologies Profit & Loss Annual

Trade
BSE: 540025 | NSE: ADVENZYMES | ISIN: INE837H01020 | Sector: Biotechnology & Drugs
367.10 +0.45 (0.12%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 623.87540.64529.38501.84
Total Revenue 623.87540.64529.38501.84
Costof Revenue Total 144.58180.44148.89133.19
Gross Profit 479.29360.20380.49368.65
Selling/ General/ Admin Expenses Total 128.37198.68172.56130.91
Depreciation/ Amortization 35.2435.0334.9828.41
Unusual Expense( Income) 15.134.750.00-3.98
Other Operating Expenses Total 146.46-5.814.85
Total Operating Expense 469.78419.71362.90294.00
Operating Income 154.09120.93166.49207.84
Interest Inc( Exp) Net- Non- Op Total -29.28-27.23-11.46-11.71
Other Net 36.6622.934.572.98
Net Income Before Taxes 187.82140.39171.06210.37
Provisionfor Income Taxes 50.8736.5247.2658.91
Net Income After Taxes 136.95103.87123.80151.46
Minority Interest -3.651.77-4.22-5.27
Net Income Before Extra Items 133.31105.64119.58146.20
Net Income 133.31105.64119.58146.20
Income Availableto Com Excl Extra Ord 133.31105.64119.58146.20
Income Availableto Com Incl Extra Ord 133.31105.64119.58146.20
Diluted Net Income 133.31105.64119.58146.20
Diluted Weighted Average Shares 11.1811.1811.1911.19
Diluted EPS Excluding Extra Ord Items 11.929.4510.6913.07
DPS- Common Stock Primary Issue 5.101.001.000.90
Diluted Normalized EPS 12.919.8110.6212.77
Research Development -8.096.476.29
Gain( Loss)on Saleof Assets --7.5111.507.25
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts